A phase I and pharmacokinetic (PK) study of high dose selenomethionine (SLM) in combination with irinotecan (IRI) in patients with advanced solid tumors

Abstract only

Saved in:

Bibliographic Details
Published in	Journal of clinical oncology Vol. 23; no. 16_suppl; p. 2080
Main Authors	Rustum, Y., Pendyala, L., Creaven, P. J., Smith, P., Azrak, R., Cao, S., Durrani, F., Lawrence, D. D., Badmaev, V., Diane, N. C., Fakih, M. G.
Format	Journal Article
Language	English
Published	01.06.2005
Online Access	Get full text

Loading…